Search hospitals > New Mexico > Albuquerque
Lovelace Medical Center-Saint Joseph Square
Claim this profileAlbuquerque, New Mexico 87102
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
101 reported clinical trials
14 medical researchers
Summary
Lovelace Medical Center-Saint Joseph Square is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Lovelace Medical Center-Saint Joseph Square is involved with conducting 101 clinical trials across 268 conditions. There are 14 research doctors associated with this hospital, such as Atul Kumar, Ursa A. Brown-Glaberman, Carolyn Y. Muller, and Neda Hashemi Sadraei.Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage III
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Atul KumarUniversity of New Mexico Cancer Center4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
38 drugs studied
Ursa A. Brown-GlabermanUniversity of New Mexico Cancer Center4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
20 reported clinical trials
45 drugs studied
Carolyn Y. MullerUniversity of New Mexico Cancer Center1 year of reported clinical research
Studies Cancer
Studies Recurrence
20 reported clinical trials
41 drugs studied
Neda Hashemi SadraeiUniversity of New Mexico Cancer Center4 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
14 reported clinical trials
40 drugs studied
Clinical Trials running at Lovelace Medical Center-Saint Joseph Square
Non-Small Cell Lung Cancer
Breast Cancer
Lung Cancer
Cancer
Gallbladder Cancer
Prostate Cancer
Renal Cell Carcinoma
Small Cell Lung Cancer
Anal Cancer
Squamous Cell Carcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Single vs Multiple Dose Radiation
for Brain Metastases
This study is designed to see if we can lower the chance of side effects from radiation in patients with breast, kidney, small cell lung cancer, non-small cell lung cancer or melanoma that has spread to the brain and who are also being treated with immunotherapy, specifically immune checkpoint inhibitor (ICI) therapy. This study will compare the usual care treatment of single fraction stereotactic radiosurgery (SSRS) given on one day versus fractionated stereotactic radiosurgery (FSRS), which is a lower dose of radiation given over a few days to determine if FSRS is better or worse at reducing side effects than usual care treatment.
Recruiting1 award N/A
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Lovelace Medical Center-Saint Joseph Square?
Lovelace Medical Center-Saint Joseph Square is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Lovelace Medical Center-Saint Joseph Square is involved with conducting 101 clinical trials across 268 conditions. There are 14 research doctors associated with this hospital, such as Atul Kumar, Ursa A. Brown-Glaberman, Carolyn Y. Muller, and Neda Hashemi Sadraei.